Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fa Wang

Showing results (881-890 of 910) with videos related to

Pageof 91
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) SeverityBarnaby E Young, Sean W X Ong, Lisa F P Ng, et al.
The Journal of Experimental Medicine|March 1, 2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infectionNina Le Bert, Hannah E Clapham, Anthony T Tan, et al.
BMC Biology|November 27, 2024
Serological evidence of sarbecovirus exposure along Sunda pangolin trafficking pathwaysBrian M Worthington, Portia Y-H Wong, Kishoree K Kumaree, et al.
Lancet (London, England)|August 22, 2020
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort studyBarnaby E Young, Siew-Wai Fong, Yi-Hao Chan, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
Frontiers in Immunology|June 11, 2021
A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19Joo Guan Yeo, Jing Yao Leong, Shi Huan Tay, et al.
Emerging Microbes & Infections|October 28, 2021
Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young menNina Le Bert, Wan Ni Chia, Wei Yee Wan, et al.
Annals of the New York Academy of Sciences|October 2, 2022
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia reportJennifer Cable, Anthony Fauci, William E Dowling, et al.
EMBO Molecular Medicine|January 7, 2022
Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infectionMatthew Zirui Tay, Angeline Rouers, Siew-Wai Fong, et al.
Pageof 91

Showing results (881-890 of 910) with videos related to

Sort By:
Pageof 91
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) SeverityBarnaby E Young, Sean W X Ong, Lisa F P Ng, et al.
The Journal of Experimental Medicine|March 1, 2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infectionNina Le Bert, Hannah E Clapham, Anthony T Tan, et al.
BMC Biology|November 27, 2024
Serological evidence of sarbecovirus exposure along Sunda pangolin trafficking pathwaysBrian M Worthington, Portia Y-H Wong, Kishoree K Kumaree, et al.
Lancet (London, England)|August 22, 2020
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort studyBarnaby E Young, Siew-Wai Fong, Yi-Hao Chan, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
Frontiers in Immunology|June 11, 2021
A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19Joo Guan Yeo, Jing Yao Leong, Shi Huan Tay, et al.
Emerging Microbes & Infections|October 28, 2021
Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young menNina Le Bert, Wan Ni Chia, Wei Yee Wan, et al.
Annals of the New York Academy of Sciences|October 2, 2022
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia reportJennifer Cable, Anthony Fauci, William E Dowling, et al.
EMBO Molecular Medicine|January 7, 2022
Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infectionMatthew Zirui Tay, Angeline Rouers, Siew-Wai Fong, et al.
Pageof 91